Published in J Urol on April 01, 1996
Economic aspects of bladder cancer: what are the benefits and costs? World J Urol (2009) 1.98
Role of p38 MAP Kinase Signal Transduction in Solid Tumors. Genes Cancer (2013) 1.73
Quality of care in patients with bladder cancer: a case report? Cancer (2011) 1.73
Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer (2011) 1.55
Mechanisms of recurrence of Ta/T1 bladder cancer. Ann R Coll Surg Engl (2010) 1.48
The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials. Eur Urol (2008) 1.21
Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling. J Cancer Res Clin Oncol (2008) 0.93
Chemoprevention of bladder cancer. World J Urol (2006) 0.90
Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer. Infect Agent Cancer (2012) 0.89
Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma. J Urol (2005) 0.88
Surveillance and treatment of non-muscle-invasive bladder cancer in the USA. Adv Urol (2012) 0.86
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301). BMC Cancer (2015) 0.86
Long-term experience with early single mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: prospective, single-centre randomised trial. World J Urol (2011) 0.85
Learning from host-defense peptides: cationic, amphipathic peptoids with potent anticancer activity. PLoS One (2014) 0.84
Single early instillation of mitomycin C and urinary alkalinization in low-risk non-muscle-invasive bladder cancer: a preliminary study. Drug Des Devel Ther (2012) 0.83
A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9. Br J Cancer (2001) 0.83
Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma. Br J Cancer (2005) 0.82
Effectiveness of an immediate mitomycin C instillation in patients with superficial bladder cancer receiving periodic mitomycin C instillation. Korean J Urol (2011) 0.78
Furosemide reverses multidrug resistance status in bladder cancer cells in vitro. J Clin Pathol (2006) 0.77
Increasing dwell time of mitomycin C in the upper tract with a reverse thermosensitive polymer. J Endourol (2012) 0.77
Bladder cancer and urothelial impairment: the role of TRPV1 as potential drug target. Biomed Res Int (2014) 0.76
Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract. Int J Clin Exp Med (2014) 0.76
Evolving immunotherapeutic strategies in bladder and renal cancer. Postgrad Med J (2004) 0.76
Preclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform. Sci Rep (2015) 0.75
Investigation of the mechanisms of action behind Electromotive Drug Administration (EMDA). PeerJ (2016) 0.75
Emerging intravesical therapies for management of nonmuscle invasive bladder cancer. Open Access J Urol (2010) 0.75
Single, immediate postoperative instillation of chemotherapy in non-muscle invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials using different drugs. Oncotarget (2016) 0.75
SKIP expression is correlated with clinical prognosis in patients with bladder cancer. Int J Clin Exp Pathol (2014) 0.75
Potential risk of mitomycin C at high concentrations on peripheral nerve structure. Neural Regen Res (2014) 0.75
What is new in non-muscle-invasive bladder cancer in 2016? Turk J Urol (2017) 0.75
Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer. ScientificWorldJournal (2015) 0.75
Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy. BMC Urol (2015) 0.75
Intravesical administration of pirarubicin against superficial bladder cancer: Relationship between tumor tissue concentration and exposure time in the bladder or therapeutic effect. Exp Ther Med (2011) 0.75
[Therapy and follow-up of bladder cancer]. Wien Med Wochenschr (2007) 0.75
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol (2001) 11.17
Kinetics of acetate metabolism during sludge digestion. Appl Microbiol (1966) 8.76
Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science (1984) 8.18
Meta-analysis of the literature or of individual patient data: is there a difference? Lancet (1993) 6.16
Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol (1997) 5.73
Tables of the number of patients required in clinical trials using the logrank test. Stat Med (1983) 5.34
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
Elongator, a multisubunit component of a novel RNA polymerase II holoenzyme for transcriptional elongation. Mol Cell (1999) 4.49
Smoking habits of oral contraceptive users. Lancet (1969) 4.20
Physical health consequences of physical and psychological intimate partner violence. Arch Fam Med (2000) 4.18
Frequency and correlates of intimate partner violence by type: physical, sexual, and psychological battering. Am J Public Health (2000) 3.93
On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics (1976) 3.82
A novel histone acetyltransferase is an integral subunit of elongating RNA polymerase II holoenzyme. Mol Cell (1999) 3.80
Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res (1978) 3.51
An analysis of birth weight by gestational age of infants born in England and Wales, 1967 to 1971. J Obstet Gynaecol Br Commonw (1974) 3.44
Identification of Plasmodium falciparum-infected mosquitoes by a double antibody enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1984) 3.00
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet (1985) 2.76
Natural history of rheumatoid cervical luxations. Ann Rheum Dis (1972) 2.63
Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention. J Urol (2004) 2.49
Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum. J Exp Med (1983) 2.48
Amplification of a highly polymorphic VNTR segment by the polymerase chain reaction. Nucleic Acids Res (1989) 2.48
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br J Cancer (2003) 2.43
Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies. Am J Epidemiol (1999) 2.40
Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol (2001) 2.33
Infectivity to mosquitoes of Plasmodium falciparum clones grown in vitro from the same isolate. Trans R Soc Trop Med Hyg (1984) 2.31
Enhancement of neural synchronization in the anteroventral cochlear nucleus. I. Responses to tones at the characteristic frequency. J Neurophysiol (1994) 2.26
Injuries sustained on "bouncy castles". BMJ (1992) 2.20
Production of goats by somatic cell nuclear transfer. Nat Biotechnol (1999) 2.19
Concomitance of psoriasis and atopic dermatitis. Dermatology (1992) 2.18
The concerns of patients under palliative care and a heart failure clinic are not being met. Palliat Med (2001) 2.18
Is a male infertility clinic of any use? Br J Urol (1986) 2.16
Randomised consent designs in cancer clinical trials. Eur J Cancer (1995) 2.07
Efficacy of chlorhexidine varnish for the prevention of adult caries: a randomized trial. J Dent Res (2011) 2.06
Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study. Urology (2005) 2.01
Detection of perchlorate and the soluble chemistry of martian soil at the Phoenix lander site. Science (2009) 2.01
Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup. J Natl Cancer Inst (2000) 1.99
Dipstick haematuria and bladder cancer in men over 60: results of a community study. BMJ (1989) 1.95
Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer (1979) 1.92
Open complex formation around a lesion during nucleotide excision repair provides a structure for cleavage by human XPG protein. EMBO J (1997) 1.92
How much physical therapy for patients with stroke? Br Med J (1978) 1.91
Fistula and sinus formation in xanthogranulomatous pyelonephritis. A clinicopathological review and report of four cases. Br J Urol (1986) 1.91
The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. Stat Med (1994) 1.90
Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study. Pediatr Blood Cancer (2006) 1.90
Isolation of a Butyrate-Utilizing Bacterium in Coculture with Methanobacterium thermoautotrophicum from a Thermophilic Digester. Appl Environ Microbiol (1985) 1.90
Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum (2001) 1.85
A medium-density genetic linkage map of the bovine genome. Mamm Genome (1997) 1.85
Potential impact of genetic testing on cancer prevention trials, using breast cancer as an example. J Natl Cancer Inst (1995) 1.84
A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Stat Med (1986) 1.82
EAU guidelines on male infertility. Eur Urol (2005) 1.82
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med (1997) 1.80
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
Estimation of linkage disequilibrium in a sample of the United Kingdom dairy cattle population using unphased genotypes. J Anim Sci (2003) 1.77
Sarcomatoid carcinoma of the urinary bladder. Clinicopathologic analysis of 18 cases with immunohistochemical and electron microscopic findings. Am J Surg Pathol (1994) 1.76
Overlapping roles for the histone acetyltransferase activities of SAGA and elongator in vivo. EMBO J (2000) 1.71
The CAT-Tox (L) assay: a sensitive and specific measure of stress-induced transcription in transformed human liver cells. Fundam Appl Toxicol (1995) 1.70
The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer (1990) 1.69
Epidemiology and practice patterns of achalasia in a large multi-centre database. Aliment Pharmacol Ther (2011) 1.67
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol (1990) 1.66
Is double data entry necessary? The CHART trials. CHART Steering Committee. Continuous, Hyperfractionated, Accelerated Radiotherapy. Control Clin Trials (1994) 1.64
Vitamin D deficiency in pregnant women from a non-European ethnic minority population--an interventional study. BJOG (2002) 1.64
The effect of axial traction during orotracheal intubation of the trauma victim with an unstable cervical spine. Ann Emerg Med (1988) 1.63
Intimate partner aggression--what have we learned? Comment on Archer (2000) Psychol Bull (2000) 1.62
Plasmodium falciparum strain-specific human antibody inhibits merozoite invasion of erythrocytes. Am J Trop Med Hyg (1984) 1.62
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study. Br J Cancer (2011) 1.62
Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center. Eur Urol (1998) 1.61
Interpreting precursor studies: what polyp trials tell us about large-bowel cancer. J Natl Cancer Inst (1994) 1.61
Prognostic factors in hormone-resistant progressing cancer of the prostate. Ann Oncol (1992) 1.61
Physiological response properties of cells labeled intracellularly with horseradish peroxidase in cat ventral cochlear nucleus. J Comp Neurol (1983) 1.60
Introital enterobacteria, urinary infection, and the urethral syndrome. Lancet (1970) 1.60
Evidence for a mediator cycle at the initiation of transcription. Proc Natl Acad Sci U S A (1997) 1.60
Chronic disease in former college students. II. Methods of study and observations on mortality from coronary heart disease. Am J Public Health Nations Health (1966) 1.58
Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res (1999) 1.58
Detection of single-nucleotide polymorphisms with the WAVE DNA fragment analysis system. Genet Test (1999) 1.57
Can energy adjustment separate the effects of energy from those of specific macronutrients? Am J Epidemiol (1994) 1.56
Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis. Br J Ophthalmol (1999) 1.55
TNM classification of genitourinary tumours 1987--position of the EORTC Genitourinary Group. Br J Urol (1988) 1.55
A study of 52 cases of adenocarcinoma of the bladder. Br J Urol (1971) 1.53
Detection of synchrony in the activity of auditory nerve fibers by octopus cells of the mammalian cochlear nucleus. Proc Natl Acad Sci U S A (2000) 1.51
Encoding timing and intensity in the ventral cochlear nucleus of the cat. J Neurophysiol (1986) 1.50
Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer. Br J Urol (1992) 1.50
Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer (1991) 1.49
The use of a Kolmogorov--Smirnov type statistic in testing hypotheses about seasonal variation. J Epidemiol Community Health (1979) 1.49
Construction of bovine whole-genome radiation hybrid and linkage maps using high-throughput genotyping. Anim Genet (2007) 1.49
Influence of tidal volume on the distribution of gas between the lungs and stomach in the nonintubated patient receiving positive-pressure ventilation. Crit Care Med (1998) 1.48
On the nature and extent of XY pairing at meiotic prophase in man. Cytogenet Cell Genet (1984) 1.46
Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci (2000) 1.43
Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity. J Clin Invest (1975) 1.42
Fluid intake compared with established standards and symptoms of dehydration among elderly residents of a long-term-care facility. J Am Diet Assoc (1999) 1.42
Bayesian monitoring of phase II trials in cancer chemoprevention. J Clin Epidemiol (1999) 1.41
Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br J Cancer (1995) 1.41
A stratified Wilcoxon-type test for trend. Stat Med (1990) 1.40
Coincidence detection in the auditory system: 50 years after Jeffress. Neuron (1998) 1.39
The future of prognostic factors in outcome prediction for patients with cancer. Cancer (1992) 1.39